US · Healthcare

Australis Capital Inc (AUSAF)

Drug Manufacturers - Specialty & Generic

Australis Capital Inc (AUSAF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AUSAF

P/E ratio

18.00

Australis Capital Inc (AUSAF) — FAQ

What is AUSAF's P/E ratio?

The price-to-earnings (P/E) ratio for Australis Capital Inc (AUSAF) is 18.00 (data as of 2026-03-23).

Does Australis Capital Inc pay a dividend?

Dividend yield is not available in the current snapshot for Australis Capital Inc (AUSAF). Check the MyAverix Finance app for the latest dividend data.

What sector is Australis Capital Inc in?

Australis Capital Inc (AUSAF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is AUSAF listed on?

AUSAF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)